Rafarma Closes Biocogency Merger
October 19, 2020 09:15 ET
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that it has closed the merger with BIOCOGENCY LABORATORIES. The new consolidated...
Rafarma Approves Issuance of Majority of Voting Shares to Board Chairman Ilya Shpurov
October 06, 2020 10:13 ET
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce approval of Ilya Shpurov receiving the majority of Preferred B shares,...
Rafarma Conducts Strategy Conference in Thailand for University and Hospital Joint Venture
September 02, 2020 11:01 ET
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) reports that Mr. Anucha Pehtpeng, Rafarma’s Director of Thai Operations, represented the company...
Rafarma Establishes Thailand Corporate Entity For Merger and Expansion Projects
August 25, 2020 11:13 ET
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. “OTC:(RAFA)” is pleased to announce that it has established a new corporate entity in Thailand. The entity is...
Rafarma - Biocogency Acquisition Progresses to Preparation of GAAP Financials and Form 10 Drafting for Full SEC Reporting
August 14, 2020 09:15 ET
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Aug. 14, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to update its shareholders on the progress of its acquisition by the R. & D. BIOCOGENCY...
Letter to Shareholders Regarding Rafarma Acquisition by R. & D. Biocogency Laboratories Inc.
August 05, 2020 09:15 ET
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) presents the following letter to Rafarma shareholders from CEO Vladimir Dolgolenko: To Our...
Rafarma to be Acquired by R. & D. Biocogency Laboratories Inc.
August 04, 2020 09:15 ET
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that it has reached an agreement to be acquired by R. & D. Biocogency...
Rafarma Inks Deal For CBD-Infused Drink Product
June 22, 2020 09:15 ET
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, June 22, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce finalization of the agreement with Destination Marketing Group Co. Ltd....
Rafarma Finalizes Announces New Product
June 15, 2020 10:48 ET
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, June 15, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, (OTC:(RAFA) Inc. is happy to announce commencement of tests for its new product “HempySleep”. The product was designed...
Protect Pharmaceutical Commences Production of a New Kind of Green: Cannabis-Based “Green Wine”
May 28, 2020 11:58 ET
|
PROTECT PHARMACEUTICAL Corp
Sevnica, Slovenia, May 28, 2020 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. “OTC:(PRTT)” Protect Pharmaceutical Corp is excited to announce the commencement of its production of cannabis-based...